Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Overall, PSMA-PET/CT detected distant metastasis in 84 of 182 cases (46%) that were negative by other types of imaging, ...

Keck Medicine of USC is participating in a national, multisite clinical trial examining if a water vapor system that uses ...

Francis Medical Inc., a Twin Cities med-tech manufacturer that's developing a way to treat prostrate and other cancers with water vapor, said Tuesday it raised $80 million in its latest equity funding ...

Keck Medicine of USC is participating in a national, multisite clinical trial examining if a water vapor system that uses ...

Researchers at The Clatterbridge Cancer Centre are using artificial intelligence (AI) to improve radiotherapy for prostate ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

Researchers conducted a retrospective study using data from 182 subjects with high-risk recurrent prostate cancers.

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) frequently detects metastatic disease missed by conventional imaging, investigators report.